Search
Search Results
##search.searchResults.foundPlural##
-
THE GUT MICROBIOTA AND IMMUNE SYSTEM RELATIONSHIP IN HUMAN GRAFT-VERSUS-HOST DISEASE
6601PDF: 2290HTML: 14187Untitled: 273figure: 245 -
PROPHYLAXIS OF MALARIA
3188PDF: 1144HTML: 18086Figures SChwartz: 227 -
AN OBSERVATIONAL STUDY OF THE EFFECT OF HEMOGLOBINOPATHY, ALPHA THALASSEMIA AND HEMOGLOBIN E ON P. VIVAX PARASITEMIA
4069PDF: 1013HTML: 488Distribution of malaria patient cohort along Thailand and borders during 2011-2012: 268 -
THERAPY-RELATED MYELOID MALIGNANCIES IN MYELOMA
2687PDF: 893HTML: 1769 -
-
The MINI-POLATUZUMAB VEDOTINE PLUS CHP (POLA-R-CHP) VS. MINI-R-CHOP IN PATIENTS OVER 80 YEARS OF AGE WITH DIFFUSE LARGE B-CELL LYMPHOMA: A RETROSPECTIVE, PROPENSITY SCORE-MATCHED ANALYSIS STRATIFIED BY SIMPLIFIED FRAILTY SCORE PolaRCHP vs. RCHOP for older patients
1629PDF: 598HTML: 366 -
VITAMIN D STATUS IN THALASSEMIA MAJOR: AN UPDATE
2958PDF: 1217HTML: 2709 -
IMMUNOGLOBULIN GENE REPERTOIRE IN CHRONIC LYMPHOCYTIC LEUKEMIA: INSIGHT INTO ANTIGEN SELECTION AND MICROENVIRONMENTAL INTERACTIONS
3347PDF: 984HTML: 7329Kost Fig1: 249Kost Fig 2: 231Kost Fig3: 252Kost Fig 4: 266Kost Fig5: 255Kost fig 6: 250 -
TREATMENT OF EARLY STAGES HODGKIN LYMPHOMA DURING PREGNANCY
4332PDF: 1210HTML: 928 -
Skin Manifestations associated with Mantle cell Lymphoma: a case report
1734PDF: 895HTML: 2223Untitled: 291Untitled: 261Untitled: 249Untitled: 283Untitled: 275 -
SUSTAINED REMISSION IN AN ELDERLY PATIENT WITH ACUTE MYELOID LEUKEMIA FOLLOWING GILTERITINIB TREATMENT AS THIRD-LINE SALVAGE THERAPY Long-lasting disease remission with third line therapy with gilteritinib
1125PDF: 603HTML: 354 -
Common variable immunodeficiency due to a novel NFKB1 variant in a child with thalassemia major CVID with thalassemia major
892PDF: 661HTML: 211 -
OUTCOME OF ANTIFUNGAL COMBINATION THERAPY FOR INVASIVE MOLD INFECTIONS IN HEMATOLOGICAL PATIENTS IS INDEPENDENT OF THE CHOSEN COMBINATION
1351PDF: 601HTML: 1730Figures: 226Fifures Sanz: 234tables Sanz: 239Untitled: 230 -
MONITORING THE RESPONSE TO TYROSINE KINASE INHIBITOR (TKI) TREATMENT IN CHRONIC MYELOID LEUKEMIA (CML)
4258PDF: 1680HTML: 9336Untitled: 367Untitled: 241Untitled: 228Untitled: 246Untitled: 239Untitled: 410 -
Can Polycythemia Vera evolve from Acute Myeloid Leukemia? A Case Report Showing a Simultaneous Minor JAK2 V617F Mutated Clone, De novo polycythemia vera following AML remission
1916PDF: 891HTML: 325 -
HEMATOPOIETIC CELL TRANSPLANTATION FOR OLDER PATIENTS WITH MDS
2282PDF: 867HTML: 3295 -
EPIDEMIOLOGY OF MALARIA IN THE STATE OF QATAR, 2008-2015
2142PDF: 1144HTML: 503 -
How we manage invasive fungal disease in acute myeloid leukemia patients with Glucose 6 Dehydrogenase deficiency
1970PDF: 1018HTML: 1040Referring article: 814 -
DISSEMINATED HISTOPLASMOSIS IN IMMUNOCOMPETENT INDIVIDUALS- NOT A SO RARE ENTITY
2588PDF: 1194HTML: 2208Untitled: 227 -
REGULATORY T-CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA
2485PDF: 1109HTML: 7730Untitled: 341Fig2: 244Fig3: 239Fig4: 270 -
CAR-T CELL THERAPY IN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA CAR-T CELL and B-ALL
4871PDF: 3997HTML: 385 -
ATRA induced Reactive Hemophagocytosis: A Case Report
1343PDF: 681HTML: 2935ATRA induced Reactive Hemophagocytosis: A Case Report: 267 -
ASSOCIATION OF VDBP RS4701 VARIANT, BUT NOT VDR/RXR-? OVER-EXPRESSION WITH BONE MINERAL DENSITY IN PEDIATRIC ?-THALASSEMIA PATIENTS Vitamin D metabolic axis and BMD in ?-thalassemia
1453PDF: 816HTML: 305 -







